IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma
Preprint in Research Square (April 2024)
The most recent citing publications are shown below. View all 55 publications that cite this research output on Dimensions.
Preprint in Research Square (April 2024)
Article in Frontiers in Oncology (April 2024)
Article in Non-coding RNA Research (February 2024)